Skip to main content
Livermore
Livermore
ZHEN

D. E. Shaw & Co., Inc.

SEC CIK
0001009207
Latest filing
Aug 14, 2026

VNDA holding history

Vanda Pharmaceuticals Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

VNDA overviewAll 13F holders of VNDAFull Q2 2026 holdings

Shares (Q1 2026)
0
Sold out in Q1 2026
Value
$0
% of portfolio
0.0%
Quarters held
20
Since Q1 2021
Holdings of VNDA by D. E. Shaw & Co., Inc., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q1 20260$00.0%−18,600−100.0%Sold outHolders
Q4 202518,600$164.1K<0.1%−103,727−84.8%ReducedHolders
Q3 2025122,327$610.4K<0.1%−41,817−25.5%ReducedHolders
Q2 2025164,144$774.8K<0.1%−26,221−13.8%ReducedHolders
Q1 2025190,365$873.8K<0.1%−113,781−37.4%ReducedHolders
Q4 2024304,146$1.46M<0.1%−255,652−45.7%ReducedHolders
Q3 2024559,798$2.63M<0.1%−132,938−19.2%ReducedHolders
Q2 2024692,736$3.91M<0.1%−1,110,106−61.6%ReducedHolders
Q1 20241,802,842$7.41M<0.1%−309,283−14.6%ReducedHolders
Q4 20232,112,125$8.91M<0.1%+164,386+8.4%AddedHolders
Q3 20231,947,739$8.41M<0.1%+666,261+52.0%AddedHolders
Q2 20231,281,478$8.44M<0.1%−81,619−6.0%ReducedHolders
Q1 20231,363,097$9.26M<0.1%+266,662+24.3%AddedHolders
Q4 20221,096,435$8.10M<0.1%+193,006+21.4%AddedHolders
Q3 2022903,429$8.93M<0.1%+51,451+6.0%AddedHolders
Q2 2022851,978$9.29M<0.1%+182,831+27.3%AddedHolders
Q1 2022669,147$7.57M<0.1%+43,087+6.9%AddedHolders
Q4 2021626,060$9.82M<0.1%−199,840−24.2%ReducedHolders
Q3 2021825,900$14.2M<0.1%−55,447−6.3%ReducedHolders
Q2 2021881,347$19.0M<0.1%+126,918+16.8%AddedHolders
Q1 2021754,429$11.3M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.